2022
DOI: 10.3389/fphar.2022.877401
|View full text |Cite
|
Sign up to set email alerts
|

Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 2 publications
0
2
0
Order By: Relevance
“…These innovations encompass diverse advancements, ranging from artificial intelligence (AI), machine learning, and deep learning to nanomedicine, 3D printing, and smart devices. Their integration is pivotal in enhancing diagnostic accuracy, tailoring personalized treatment approaches, and improving patient outcomes [46][47][48][49][50]. In cancer diagnostics, novel technologies like liquid biopsies, digital biopsies, and nanoparticle-based drug delivery systems are reshaping traditional management approaches.…”
Section: Emerging Technologies In Diagnosis and Treatmentmentioning
confidence: 99%
“…These innovations encompass diverse advancements, ranging from artificial intelligence (AI), machine learning, and deep learning to nanomedicine, 3D printing, and smart devices. Their integration is pivotal in enhancing diagnostic accuracy, tailoring personalized treatment approaches, and improving patient outcomes [46][47][48][49][50]. In cancer diagnostics, novel technologies like liquid biopsies, digital biopsies, and nanoparticle-based drug delivery systems are reshaping traditional management approaches.…”
Section: Emerging Technologies In Diagnosis and Treatmentmentioning
confidence: 99%
“…Obstacles such as incomplete knowledge of natural history make it difficult to understand the ecology and pathogenesis of rare and neglected diseases. Emerging technologies, including NGS and dPCR, provide opportunities to accelerate the diagnosis and development of treatments for these diseases [60,61]. The application of NGS in Leishmania isolates has allowed the characterization of populations through the identification and analysis of variations.…”
Section: Uses Of Nsg and Dpcr In The Diagnosis Of The Causal Agents O...mentioning
confidence: 99%